187 related articles for article (PubMed ID: 26966348)
1. Brain Histamine N-Methyltransferase As a Possible Target of Treatment for Methamphetamine Overdose.
Kitanaka J; Kitanaka N; Hall FS; Uhl GR; Takemura M
Drug Target Insights; 2016; 10():1-7. PubMed ID: 26966348
[TBL] [Abstract][Full Text] [Related]
2. Metoprine, a histamine N-methyltransferase inhibitor, attenuates methamphetamine-induced hyperlocomotion via activation of histaminergic neurotransmission in mice.
Kitanaka N; Hall FS; Kobori S; Kushihara S; Oyama H; Sasaoka Y; Takechi M; Tanaka KI; Tomita K; Igarashi K; Nishiyama N; Sato T; Uhl GR; Kitanaka J
Pharmacol Biochem Behav; 2021 Oct; 209():173257. PubMed ID: 34418452
[TBL] [Abstract][Full Text] [Related]
3. Blockade of brain histamine metabolism alters methamphetamine-induced expression pattern of stereotypy in mice via histamine H1 receptors.
Kitanaka J; Kitanaka N; Tatsuta T; Morita Y; Takemura M
Neuroscience; 2007 Jul; 147(3):765-77. PubMed ID: 17570600
[TBL] [Abstract][Full Text] [Related]
4. Are Histamine H
Kitanaka N; Hall FS; Tanaka KI; Tomita K; Igarashi K; Nishiyama N; Sato T; Uhl GR; Kitanaka J
Curr Drug Res Rev; 2022; 14(3):162-170. PubMed ID: 35431009
[TBL] [Abstract][Full Text] [Related]
5. Changes in the rat brain histamine content following metoprine and other histamine-methyltransferase (HMT) inhibitors.
Zawilska J; Nowak JZ
Pol J Pharmacol Pharm; 1985; 37(6):821-30. PubMed ID: 3832018
[TBL] [Abstract][Full Text] [Related]
6. Roles of the histaminergic neurotransmission on methamphetamine-induced locomotor sensitization and reward: a study of receptors gene knockout mice.
Takino N; Sakurai E; Kuramasu A; Okamura N; Yanai K
Int Rev Neurobiol; 2009; 85():109-16. PubMed ID: 19607964
[TBL] [Abstract][Full Text] [Related]
7. Effects of histamine agents on methamphetamine-induced stereotyped behavior and behavioral sensitization in rats.
Ito C; Onodera K; Watanabe T; Sato M
Psychopharmacology (Berl); 1997 Apr; 130(4):362-7. PubMed ID: 9160852
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment with l-histidine produces a shift from methamphetamine-induced stereotypical biting to persistent locomotion in mice.
Kitanaka J; Kitanaka N; Tatsuta T; Miyoshi A; Koumoto A; Tanaka K; Nishiyama N; Morita Y; Takemura M
Pharmacol Biochem Behav; 2010 Jan; 94(3):464-70. PubMed ID: 19895842
[TBL] [Abstract][Full Text] [Related]
9. Metoprine, an inhibitor of histamine N-methyltransferase but not catechol-O-methyltransferase, suppresses feeding in sated and in food deprived rats.
Lecklin A; Tuomisto L; MacDonald E
Methods Find Exp Clin Pharmacol; 1995; 17(1):47-52. PubMed ID: 7542717
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of brain histamine metabolism by metoprine.
Hough LB; Khandelwal JK; Green JP
Biochem Pharmacol; 1986 Jan; 35(2):307-10. PubMed ID: 3942601
[TBL] [Abstract][Full Text] [Related]
11. Inhibitors of histamine methylation in brain promote formation of imidazoleacetic acid, which interacts with GABA receptors.
Prell GD; Morrishow AM; Duoyon E; Lee WS
J Neurochem; 1997 Jan; 68(1):142-51. PubMed ID: 8978720
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment or Posttreatment with Aripiprazole Attenuates Methamphetamine-induced Stereotyped Behavior in Mice.
Kitanaka N; Kitanaka J; Hall FS; Kayama M; Sugimori H; Uhl GR; Takemura M
J Exp Neurosci; 2015; 9(Suppl 1):1-10. PubMed ID: 26525833
[TBL] [Abstract][Full Text] [Related]
13. Methamphetamine and brain histamine: a study using histamine-related gene knockout mice.
Iwabuchi K; Kubota Y; Ito C; Watanabe T; Watanabe T; Yanai K
Ann N Y Acad Sci; 2004 Oct; 1025():129-34. PubMed ID: 15542709
[TBL] [Abstract][Full Text] [Related]
14. Effects of dopamine antagonists on neuronal histamine release in the striatum of rats subjected to acute and chronic treatments with methamphetamine.
Ito C; Onodera K; Sakurai E; Sato M; Watanabe T
J Pharmacol Exp Ther; 1996 Oct; 279(1):271-6. PubMed ID: 8859003
[TBL] [Abstract][Full Text] [Related]
15. Histaminergic modulation of acoustically induced running behavior in rats.
Vinogradova LV; Shatskova AB; Tuomisto L
Brain Res; 2007 May; 1148():198-204. PubMed ID: 17362890
[TBL] [Abstract][Full Text] [Related]
16. Metoprine induced behavioral modifications and brain regional histamine increase in WAG/Rij and Wistar rats.
Samotaeva IS; Birioukova LM; Midzyanovskaya IS; Kuznetsova GD; Bazyan AS; Tuomisto L
Epilepsy Res; 2012 Aug; 101(1-2):148-56. PubMed ID: 22503455
[TBL] [Abstract][Full Text] [Related]
17. M100907 and BD 1047 attenuate the acute toxic effects of methamphetamine.
Ray A; Canal CE; Ehlen JC; Rice KC; Murnane KS
Neurotoxicology; 2019 Sep; 74():91-99. PubMed ID: 31163210
[TBL] [Abstract][Full Text] [Related]
18. Methamphetamine- and 3,4-methylenedioxymethamphetamine-induced behavioral changes in histamine H3-receptor knockout mice.
Okuda T; Zhang D; Shao H; Okamura N; Takino N; Iwamura T; Sakurai E; Yoshikawa T; Yanai K
J Pharmacol Sci; 2009 Oct; 111(2):167-74. PubMed ID: 19783867
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological effects of two anti-methamphetamine monoclonal antibodies. Supporting data for lead candidate selection for clinical development.
Laurenzana EM; Stevens MW; Frank JC; Hambuchen MD; Hendrickson HP; White SJ; Williams DK; Owens SM; Gentry WB
Hum Vaccin Immunother; 2014; 10(9):2638-47. PubMed ID: 25483484
[TBL] [Abstract][Full Text] [Related]
20. Neuronal histamine inhibits methamphetamine-induced locomotor hyperactivity in mice.
Itoh Y; Nishibori M; Oishi R; Saeki K
Neurosci Lett; 1984 Aug; 48(3):305-9. PubMed ID: 6541326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
